Literature DB >> 21999125

Quality of RCTs exploring Helicobacter pylori eradication for the prevention of gastric cancer and preneoplastic lesions.

Tian-Tian Sun1, Ji-Lin Wang, Jing-Yuan Fang.   

Abstract

Randomized controlled trials (RCTs) are considered the gold standard for evaluating the efficacy of clinical interventions and developing evidence-based clinical practice guidelines; however, they can yield biased results when their methodology is less than rigorous, or their published reports fail to report key items. A number of RCTs have been carried out to explore the relationship between Helicobacter pylori eradication and gastric cancer, but their results remain controversial. In this article, we will comprehensively review searched medical electronic databases, and appraise the reporting and methodological quality of these relevant RCTs according to the Consolidated Standards of Reporting Trials 2010 statement and the Cochrane Handbook in order to learn about the internal and external validity of these RCTs.

Entities:  

Mesh:

Year:  2011        PMID: 21999125     DOI: 10.1586/era.11.124

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  3 in total

1.  Intervention effect of pinelliae decoction for purging stomach-fire on malignant transformation of bone marrow mesenchymal stem cells in the gastric cancer microenvironment.

Authors:  Xi-Ping Liu; Hai-Xia Ming; Pei-Qing Li
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

Review 2.  The diagnosis and treatment of Helicobacter pylori infection in Arctic regions with a high prevalence of infection: Expert Commentary.

Authors:  B J McMahon; M G Bruce; A Koch; K J Goodman; V Tsukanov; G Mulvad; M L Borresen; F Sacco; D Barrett; S Westby; A J Parkinson
Journal:  Epidemiol Infect       Date:  2015-06-22       Impact factor: 2.451

3.  The efficacy of Jianpi Yiqi therapy for chronic atrophic gastritis: A systematic review and meta-analysis.

Authors:  Yun-Kai Dai; Yun-Zhan Zhang; Dan-Yan Li; Jin-Tong Ye; Ling-Feng Zeng; Qi Wang; Ling Hu
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.